Table 2. Descriptive statistics (mean ± standard deviation) of the outcomes analyzed in the different moments of assessment.
CT/DN (n = 15) CT/ShDN (n = 15) ShCT/DN (n = 15) Between-groups analysis
PPT (N/cm) Baseline 84.3 ± 7.6 86.2 ± 6.2 85.6 ± 5.6 F = 0.320; p = 0.728; ηp2 = 0.015
Post. exe 78.3 ± 7.7 81.3 ± 7.2 80.7 ± 6.2 F = 0.719; p = 0.493; ηp2 = 0.033
PostTh5min 82.7 ± 7.7 86.3 ± 7.1 83.7 ± 5.8 F = 1.076; p = 0.350; ηp2 = 0.049
PostTh24h 85.3 ± 7.4 87.5 ± 6.0 85.5 ± 5.6 F = 0.564; p = 0.573; ηp2 = 0.0026
MT (Hz) Baseline 19.6 ± 0.8 19.3 ± 0.7 19.3 ± 0.6 F = 0.896; p = 0.416; ηp2 = 0.041
Post. exe 24.7 ± 1.2 24.3 ± 0.9 24.2 ± 0.9 F = 0.941; p = 0.398; ηp2 = 0.043
PostTh5min 14.7 ± 1.2b 16.2 ± 1.0a 15.4 ± 1.3 F = 5.967; p = 0.005*; ηp2 = 0.221
PostTh24h 16.5 ± 0.8 17.2 ± 0.9 16.5 ± 1.2 F = 2.833; p = 0.070; ηp2 = 0.119
PU (A.U.) Baseline 10.1 ± 0.7 10.2 ± 0.7 9.9 ± 0.7 F = 0.576; p = 0.567; ηp2 = 0.027
Post. exe 13.4 ± 0.5 13.1 ± 0.7 13.3 ± 0.5 F = 1.413; p = 0.255; ηp2 = 0.063
PostTh5min 18.2 ± 1.2b,c 15.7 ± 1.0a,c 13.6 ± 0.5a,b F = 85.020; p<0.001*; ηp2 = 0.802
PostTh24h 13.0 ± 0.9b,c 11.7 ± 0.8a,c 10.7 ± 0.6a,b F = 32.726; p<0.001*; ηp2 = 0.609
Fmax (kgf) Baseline 50.7 ± 4.9 51.2 ± 5.5 51.8 ± 4.7 F = 0.167; p = 0.847; ηp2 = 0.008
Post. exe 45.5 ± 5.1 46.2 ± 5.1 44.0 ± 2.8 F = 0.968; p = 0.388; ηp2 = 0.044
PostTh5min 50.5 ± 5.7 50.0 ± 5.0 53.6 ± 5.2 F = 2.037; p = 0.143; ηp2 = 0.088
PostTh24h 53.4 ± 5.6 51.1 ± 4.6 52.9 ± 5.5 F = 0.813; p = 0.450; ηp2 = 0.037
CT: compression contrast therapy; DN: dry needling; Sh: sham; Fmax: isometric muscle strength; MT: muscle tension; PPT: pressure pain threshold; PU: perfusion unit; Post. exe: post muscle fatigue; PostTh5min: post 5 minutes of the intervention; PostTh24h: post 24 hours of the intervention; a: significantly different (p < 0.05) from CT/DN; b: significantly different (p < 0.05) from CT/ShDN; c: significantly different (p < 0.05) from ShCT/DN;*: significantly different (p < 0.05).